Thermo Fisher's Tariff Refunds Supplied 15 Cents Of Third-Quarter EPS, Biggest Piece Of Beat
The CFO said the one-time refunds were not in guidance and were partly reinvested in AI, pharma-services capacity and employees.
Thermo Fisher got a net $60 million boost to adjusted operating income from tariff refunds in the third quarter, or 15 cents of adjusted earnings per share, CFO Jim Meyer told analysts on the company's earnings call. The refunds were not in prior guidance, and Meyer said part of the money was reinvested rather than left to drop to profit.
What the CFO said about the refunds
Meyer said Thermo Fisher received approvals and booked recovery on "the vast majority" of its total potential refund claims. The net hit to adjusted operating margin was 50 basis points, or half a percentage point, and the revenue effect was negligible.
The net figure already includes reinvestment during the quarter: faster AI deployment across the company, extra support for new capacity in pharma services, and added spending on employees. Meyer called the one-time refunds "a unique opportunity to make incremental short-term investments."
Adjusted EPS came in 26 cents above prior guidance, Meyer said. Eight cents came from operations, 3 cents from currency and 15 cents from the refunds, making the refunds the largest piece.
What it changes for the year
Full-year adjusted EPS guidance rose $0.15 at the midpoint, to a range of $25.13 to $25.43. Meyer split the raise three ways: $0.09 from operations, $0.05 from the net effect of the refunds after about $40 million of additional fourth-quarter reinvestment, and $0.01 from currency.
Guidance still assumes 80 basis points of adjusted operating margin expansion for the year. Free cash flow guidance rose to $7 billion to $7.5 billion.
Third-quarter results themselves: revenue grew 9% to $12.14 billion, adjusted operating income rose 15% to $2.97 billion at a 24.5% margin, and adjusted EPS rose 15% to $6.68. Organic revenue grew 6%.
On growth, Meyer said organic growth was 3% in the first half and is now expected at 5% in the second half, up from 4%. Pharma services activity was weighted toward the third quarter, he said, and the company is holding fourth-quarter organic growth at 4%.
What to watch
CEO Marc Casper said fourth-quarter results and 2027 guidance arrive February 2 at 8:30 a.m. He said the company will highlight AI and how it sees the market playing out at that point.
The next test of the refund math comes February 2, when Thermo Fisher gives 2027 guidance without a one-time recovery to lean on.
Sources
- Thermo Fisher: Q3 Earnings Snapshot — Associated Press
- Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings — benzinga.com
- Thermo Fisher stock gains on Q3 beat (TMO:NYSE) | Seeking Alpha — seekingalpha.com
- Thermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue Estimates — Yahoo Finance
- Thermo Fisher (TMO) Reports Earnings Tomorrow: What To Expect — Yahoo Finance